In gastric adenocarcinoma, HER2 expression can be quite heterogeneous and mostly there is incomplete membrane staining, which is the basis for a different criterion for HER2 scoring in gastric cancer when compared to breast cancer [11]. The gene discussed is ERBB2; the disease is breast cancer.